Home Topics
Topics
Level 1:
CarbonCatalyticEnergyFabricationMaterial compositionMorphologyNano biologyNano detectionNano deviceNano unitSemiconductorSynthesisTheory
Level 2:
ALLBiotechnologyCellDiagnosisDiseasesDrug deliveryGenes Therapy TissueTumors
Level 3:
ALLControlled drug deliveryDrug deliveryMedical problemsMelaninMetabolismMetabolitesMolecular biologyTargeted drug delivery
Research Article | Open Access
Biomimetic arsenic trioxide nanoplatform induces Caspase-3/GSDME pyroptosis and remodels the glioma immune microenvironment
Available online: 21 September 2026
Review Article | Open Access
Programmable long-acting injectable nanomedicines for chronic inflammation
Available online: 21 September 2026
Review Article | Open Access
The next generation of lipid nanoparticles for in vivo engineering and targeted delivery
Published: 30 July 2026
2026, 19(10): 94908949
Research Article | Open Access
Mitochondria-mimetic nanomedicine restores mitochondrial homeostasis to rescue traumatic and osteoporotic bone loss
Published: 23 July 2026
2026, 19(9): 94908884
Research Article | Open Access
Reticuloendothelial system blockade-assisted redirection of celastrol-loaded nanomedicine to glomeruli for treatment of mesangioproliferative glomerulonephritis
Published: 15 July 2026
2026, 19(9): 94908676
Research Article | Open Access
cCLT1-decorated nanodisk as a novel cancer-associated fibroblast-targeted curcumin delivery system for enhanced breast tumor metastasis treatment by TME remodeling
Published: 23 June 2026
2026, 19(8): 94908905
Review Article | Open Access
Advanced lipid nanoparticles for targeted nucleic acid delivery
Published: 22 June 2026
2026, 19(8): 94908809
Research Article | Open Access
Drug delivery system targeting acid sphingomyelinase reduction in vascular endothelial and neuronal cells to restore autophagy in Alzheimer's therapy
Published: 22 June 2026
2026, 19(8): 94908783
Research Article | Open Access
Ratio-tunable nucleic acid nanohybrids enable precision therapy for esophageal squamous cell carcinoma
Published: 19 May 2026
2026, 19(6): 94908592
Research Article | Open Access
An injectable AsCu-nanocomposite hydrogel breaks the pathological triad of acute osteomyelitis via synergistic bactericidal and macrophage-reprogramming therapy
Available online: 04 February 2026
Total 109